Synageva BioPharma to Present at Morgan Stanley Global Healthcare Conference
LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare disorders (“Synageva”), announced today that it will be presenting at the upcoming Morgan Stanley Global Healthcare Conference on Tuesday, September 13, 2011, at 9:45AM Eastern Daylight Time in New York, NY.